These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23959894)

  • 1. Nonhuman primate model of schizophrenia using a noninvasive EEG method.
    Gil-da-Costa R; Stoner GR; Fung R; Albright TD
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15425-30. PubMed ID: 23959894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology.
    Schuelert N; Dorner-Ciossek C; Brendel M; Rosenbrock H
    Physiol Rep; 2018 Aug; 6(16):e13782. PubMed ID: 30155997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
    Roser P; Haussleiter IS; Chong HJ; Maier C; Kawohl W; Norra C; Juckel G
    Psychopharmacology (Berl); 2011 Dec; 218(4):611-20. PubMed ID: 21590281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses.
    Takahashi H; Rissling AJ; Pascual-Marqui R; Kirihara K; Pela M; Sprock J; Braff DL; Light GA
    Neuroimage; 2013 Feb; 66():594-603. PubMed ID: 23085112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
    Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
    J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction.
    Shelley AM; Silipo G; Javitt DC
    Schizophr Res; 1999 May; 37(1):65-79. PubMed ID: 10227109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamatergic modulation of auditory information processing in the human brain.
    Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
    Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
    Rosburg T; Kreitschmann-Andermahr I
    Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice.
    Ehrlichman RS; Maxwell CR; Majumdar S; Siegel SJ
    J Cogn Neurosci; 2008 Aug; 20(8):1403-14. PubMed ID: 18303985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic sensory information processing abnormalities across the illness course of schizophrenia.
    Jahshan C; Cadenhead KS; Rissling AJ; Kirihara K; Braff DL; Light GA
    Psychol Med; 2012 Jan; 42(1):85-97. PubMed ID: 21740622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
    Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of ketamine on auditory steady-state responses in intact, awake macaques: A non-human primate model of schizophrenia.
    Nakamura T; Dinh TH; Asai M; Matsumoto J; Nishimaru H; Setogawa T; Honda S; Yamada H; Mihara T; Nishijo H
    Brain Res Bull; 2023 Feb; 193():84-94. PubMed ID: 36539101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.
    Javitt DC; Zukin SR; Heresco-Levy U; Umbricht D
    Schizophr Bull; 2012 Sep; 38(5):958-66. PubMed ID: 22987851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.
    Javitt DC
    Ann N Y Acad Sci; 2015 May; 1344():92-104. PubMed ID: 25721890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia.
    Jahshan C; Wynn JK; Mathis KI; Altshuler LL; Glahn DC; Green MF
    Bipolar Disord; 2012 May; 14(3):239-48. PubMed ID: 22548897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.
    Featherstone RE; Shin R; Kogan JH; Liang Y; Matsumoto M; Siegel SJ
    Neurobiol Dis; 2015 Jan; 73():289-95. PubMed ID: 25461194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.
    Hochberger WC; Joshi YB; Zhang W; Thomas ML; ; Braff DL; Swerdlow NR; Light GA
    Int J Psychophysiol; 2019 Nov; 145():23-29. PubMed ID: 30586570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.